19
Participants
Start Date
February 3, 2015
Primary Completion Date
January 14, 2016
Study Completion Date
January 14, 2016
PF-03084014
Tablet, 10 mg, twice a day.
PF-03084014
Tablet, 50 mg, twice a day
PF-03084014
Tablet, 100 mg, twice a day
Debreceni Egyetem, Klinikai Kozpont, Onkologiai Intezet, Debrecen
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center Sleepy Hollow, Sleepy Hollow
Memorial Sloan Kettering Cancer Center West Harrison, Harrison
Memorial Sloan Kettering Cancer Center Rockville Centre, Rockville Centre
Memorial Sloan Kettering Cancer Center Commack, Commack
Complejo Hospitalario Universitario A Coruna (Hospital Teresa Herrera), A Coruña
Istitutio Europeo di Oncologia, Milan
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario 12 de Octubre, Madrid
Vesalius, Krakow
Vesalius Poradnia Onkologiczna i Hematologiczna, Krakow
Hospital Universitario Virgen del Rocio, Seville
Hospital Clínico Universitario de Valencia, Valencia
Midwestern Regional Medical Center, Zion
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
The University of Chicago Medical Center, Chicago
University of Chicago Medical Center, Chicago
Presidio Ospedaliero Vito Fazzi, Lecce
Stanford Cancer Institute, Stanford
Stanford Hospital and Clinics, Stanford
Stanford Women's Cancer Center, Stanford
Brigham and Women's Hospital (BWH), Boston
Dana-Farber Cancer Institute (DFCI), Boston
Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge
The Valley Hospital - Luckow Pavilion, Paramus
Valley Medical Group, Paramus
Valley Medical Group, Westwood
Szpital Kliniczny Przemienienia Panskiego, Uniwersutetu Medycznego im. Karola Marcinkowskiego, Poznan
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Instituto Catalan de Oncologia de L'Hospitalet de Llobregat (ICO), Barcelona
Beatson West of Scotland Cancer Centre, Glasgow
Ross Hall Hospital, Glasgow
The Royal Marsden NHS Foundation Trust, London
The Royal Marsden NHS Foundation Trust, Surrey
Lead Sponsor
Pfizer
INDUSTRY